BioPharm International
May 01, 2012
Perspectives on Outsourcing
25
5
Service providers must focus on delivering a superior customer experience.
May 01, 2012
Features
25
5
This month, we rewind to an article titled "The Biotechnology Industry: A First Quarter Snapshot."
May 01, 2012
Features
25
5
The author highlights novel strains and methods that have recently been shown to express multidisulfide bonded proteins.
May 01, 2012
Features
25
5
This article discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.
May 01, 2012
Features
25
5
The author describes expression technology that produces cell lines with high genetic stability.
May 01, 2012
Regulatory Beat
25
5
Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
May 01, 2012
Features
25
5
MAb polishing using salt tolerant interaction membrane chromatography.
May 01, 2012
Features
25
5
A Q&A with Alan Shaw of Vaxinnate. This article is part of a special section on expression systems.
May 01, 2012
Final Word
25
5
Future sponsor-contract provider relationships will require more integration.
May 01, 2012
Features
25
5
Featuring expert insights from GSK Biologicals, Baxter Pharmaceutical Solutions, GEA Pharma Systems, and more.
May 01, 2012
From the Editor
25
5
No matter the time or cost, knowing what's going on inside your facilities is always going to be worth the effort.
May 01, 2012
Compliance Notes
25
5
How to handle and respond to a consent decree.
May 01, 2012
Boot Camp Business Guide
25
5
BioPharm talks with Tarja Mottram, CEO of Action for Results, on design-for-value concepts, management, and cross-functionality.